USA:

Europe:

Email:

Consultation

GLP-1 (7-36), active ELISA

  • Product Information
  • Description
Catalog: C0835T
Product Type: Test kit
Unit: 96 tests
Regulatory status: RUO
Incubation time: 1 x 20-24 h, 1 x 20 min
Standard range: 0.64 - 48 pmol/L
Sample type: Serum, EDTA-plasma
Sample requirements: 100 µL
Isotope/Substrate: TMB 450nm
Analysis mode: ELISA
Application: Metabolic Syndrome

Incretins are a group of gastrointestinal hormones that cause an increase in the amount of insulin released from the beta cells of the islets of Langerhans after eating. They also inhibit glucagon release from the alpha cells of the islets of Langerhans. As a result, they slow the rate of absorption of nutrients into the blood stream by reducing gastric emptying and may directly reduce food intake. The two main candidate molecules that fulfill criteria for an incretin are glucagon-like peptide-1 (GLP-1) and Gastric inhibitory peptide (or glucose-dependent insulinotropic polypeptide or GIP). GLP-1 (7-36) amide and GLP-1 (7-37) are known as active forms of GLP-1. They are rapidly inactivated to GLP-1 (9-36) amide and GLP-1 (9-37) by DPP-IV within a few moments in blood. This ELISA kit can measure active forms of GLP-1 (GLP-1 (7-36) amide and GLP-1 (7-37)) specifically.

Verification Code

Diagnostic Development

top